Acetyl‐L‐carnitine vs placebo
All‐cause mortality · patients with covert or overt hepatic encephalopathy
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Findings
What do systematic reviews say?
7 questions · 7 findings · 1 reviews · Hepato-Biliary
No studies found 0 · 0%GRADE not reported 3 · 42.9%Very low 3 · 42.9%Low 1 · 14.3%Moderate 0 · 0%High 0 · 0%
Acetyl‐L‐carnitine vs placebo
General health‐related quality of life · patients with covert or overt hepatic encephalopathy
1 finding from 1 review
- no estimate extracted1 study · 67 participantsVery low
Acetyl‐L‐carnitine vs placebo
Serious adverse events · patients with covert or overt hepatic encephalopathy
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Acetyl‐L‐carnitine vs placebo
Fatigue Mental fatigue in moderate‐grade hepatic encephalopathy Wessely and Powell test Scale from 0 to 10 · patients with covert or overt hepatic encephalopathy
1 finding from 1 review
- no estimate extracted1 study · 121 participantsVery low
Acetyl‐L‐carnitine vs placebo
Non‐serious adverse events · patients with covert or overt hepatic encephalopathy
It is very uncertain whether acetyl‐L‐carnitine changes non‐serious adverse events compared with placebo (very low certainty).
1 finding from 1 review
- RR 2.51 [0.68, 9.22]2 studies · 246 participantsVery low
Acetyl‐L‐carnitine vs placebo
Number of days in hospital (duration of hospitalisation) · patients with covert or overt hepatic encephalopathy
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Acetyl‐L‐carnitine vs placebo
Blood ammonium levels · patients with covert or overt hepatic encephalopathy
1 finding from 1 review
- no estimate extracted5 studies · 387 participantsLow